Disease | lennox-gastaut syndrome |
Symptom | C0259813|drop attacks |
Sentences | 2 |
PubMedID- 23083943 | Purpose: rufinamide is a novel antiepileptic drug (aed), which is known to be effective in the treatment of partial seizures and drop attacks in patients with lennox-gastaut syndrome (lgs). |
PubMedID- 21481742 | Rufinamide is a new orally active antiepileptic drug that has been found to be effective in the treatment of partial seizures and drop attacks associated with lennox-gastaut syndrome. |
Page: 1